4//SEC Filing
Spear Matthew A. 4
Accession 0001209191-21-048793
CIK 0001661460other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:29 PM ET
Size
9.9 KB
Accession
0001209191-21-048793
Insider Transaction Report
Form 4
Spear Matthew A.
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-07-28−20,000→ 94,861 totalExercise: $1.32Exp: 2026-06-19→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2021-07-28$1.32/sh+20,000$26,440→ 41,485 total
Footnotes (1)
- [F1]The stock option is fully vested and exercisable.
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001766302
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:29 PM ET
- Size
- 9.9 KB